AKT1 and acute myeloid leukemia: Importantly, the authors found that simultaneously blocking phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/MTOR and BCL2-associated cell signaling pathways was an effective means to deter stromal-mediated AML survival.